Results 201 to 210 of about 46,054 (219)
Some of the next articles are maybe not open access.
The Journal of Cardiovascular Surgery
Endovascular arterial recanalization has become the mainstay therapy for peripheral arterial occlusive disease. Although immediate technical success is achieved in greater than 90% of cases, longer-term results continue to vary based on the clinical presentation, and the treated target lesion.
El Khoury, Rym +5 more
openaire +3 more sources
Endovascular arterial recanalization has become the mainstay therapy for peripheral arterial occlusive disease. Although immediate technical success is achieved in greater than 90% of cases, longer-term results continue to vary based on the clinical presentation, and the treated target lesion.
El Khoury, Rym +5 more
openaire +3 more sources
In-stent Restenosis of drug-eluting Stents
Future Cardiology, 2013Drug-eluting stents (DES) have emerged as an improved alternative to bare-metal stents by demonstrating reduced rates of restenosis and target lesion revascularization. This emergence has led to the unrestricted use of DES for various indications and lesions, and subsequently revealed DES in-stent restenosis as a novel interventional therapeutic ...
Ron Waksman +2 more
openaire +2 more sources
Late Restenosis Following Placement of a Sirolimus Eluting Stent for In-Stent Restenosis
Heart, Lung and Circulation, 2007Drug eluting stents (DES) are rapidly replacing intravascular brachytherapy for the treatment of bare metal in-stent restenosis (ISR). To date, there are no long-term follow up data supporting this practise. We report symptomatic repeat in-stent restenosis occurring 27 months after sirolimus eluting stent deployment for de novo in-stent restenosis ...
David Brieger +3 more
openaire +3 more sources
2003
In 1998, 539,000 percutaneous transluminal coronary angioplasty (PTCA) procedures were performed in the United States, an increase of 248% since 1987 [1]. Most of these interventions were followed by stenting. The advent of stents has revolutionized interventional cardiology; however, the Achilles’ heel of stenting is in-stent restenosis (ISR). In this
Verghese Mathew, Ali E. Denktas
openaire +2 more sources
In 1998, 539,000 percutaneous transluminal coronary angioplasty (PTCA) procedures were performed in the United States, an increase of 248% since 1987 [1]. Most of these interventions were followed by stenting. The advent of stents has revolutionized interventional cardiology; however, the Achilles’ heel of stenting is in-stent restenosis (ISR). In this
Verghese Mathew, Ali E. Denktas
openaire +2 more sources
Third in‐stent restenosis in sirolimus eluting stents
Catheterization and Cardiovascular Interventions, 2012AbstractObjectives:We evaluated the predictive factors for recurrent restenosis lesions treated on two previous occasions with sirolimus‐eluting stents (SES).Background:Angiography data related to recurrent SES restenosis have not been reported.Methods:Binary restenosis was observed in 66 patients with 78 lesions from a total of 1,393 patients with 1 ...
Yoshiharu Higuchi +10 more
openaire +3 more sources
Novel Stents for the Prevention of Restenosis
Trends in Cardiovascular Medicine, 1997Since the introduction of Interventional Cardiology in 1976, there has been rapid expansion both in its clinical application and the tools of the trade. This growth was accelerated with the introduction of the intra-coronary stent in 1987. The demonstration that stents may reduce the incidence of restenosis after percutaneous coronary revascularization
Charles J. McKenna +2 more
openaire +3 more sources
Restenosis after aortic stenting
Cardiology in the Young, 2004Aortic coarctation is a recognized arteriopathy in patients with Williams’ syndrome. We present an adolescent with Williams’ syndrome who developed rapid restenosis after primary stenting of coarctation of the aorta. We believe such restenosis within the stent is due to a proliferative response of the abnormal aortic wall.
Derek Roebuck +2 more
openaire +3 more sources
Intracoronary Stent Restenosis
2021Despite contemporary drug-eluting stent (DES) technology, intracoronary stent restenosis (ISR) occurs in up to 10% of patients, increasing with intervention of complex lesions. The presentation of ISR is still challenging for optimal treatment [1].
Annapoorna Kini +2 more
openaire +2 more sources
Stent restenosis in a Chinese population
International Journal of Cardiology, 2005Stents are now widely used in Hong Kong and China and there is a clinical impression that restenosis is less common because of the lower prevalence of coronary artery disease and associated risk factors in the Chinese. However, there are no published data on angiographic stent restenosis rates in Chinese patients.In a prospective study of 114 ...
Philip H.C. Wong +5 more
openaire +3 more sources
Italian heart journal : official journal of the Italian Federation of Cardiology, 2001
Even after optimal immediate results, restenosis still occurs in a relevant percentage of patients after stent implantation. This disappointing outcome has strong clinical and socio-economical implications and has become a major target of research in cardiology.
openaire +2 more sources
Even after optimal immediate results, restenosis still occurs in a relevant percentage of patients after stent implantation. This disappointing outcome has strong clinical and socio-economical implications and has become a major target of research in cardiology.
openaire +2 more sources